Antenatal depression, treatment with selective serotonin reuptake inhibitors, and neonatal brain structure: A propensity-matched cohort study

Psychiatry Research - Neuroimaging

Volumn 253, Issue , 2016, Pages 43-53

  Jha, Shaili C ^a   Meltzer Brody, Samantha ^b   Steiner, Rachel J ^c   Cornea, Emil ^d   Woolson, Sandra ^e   Ahn, Mihye ^f   Verde, Audrey R ^b   Hamer, Robert M ^b,d   Zhu, Hongtu ^d   Styner, Martin ^b,g   Gilmore, John H ^a,b   Knickmeyer, Rebecca C ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d University of North Carolina at Chapel Hill   (United States)

^e DURHAM VA MEDICAL CENTER   (United States)

^f UNIVERSITY OF NEVADA   (United States)

^g University of North Carolina   (United States)

Author keywords

Antidepressant; Depression; Diffusion tensor imaging; Fetal development; Infant, Newborn; Magnetic resonance imaging

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ARTICLE; BRAIN DEVELOPMENT; BRAIN REGION; BRAIN SIZE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DRUG EXPOSURE; FEMALE; FETUS DEVELOPMENT; GRAY MATTER; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NEUROANATOMY; NEUROIMAGING; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUERPERAL DEPRESSION; QUANTITATIVE ANALYSIS; TRACTOGRAPHY; WHITE MATTER; ADULT; BRAIN; DEPRESSION; DIAGNOSTIC IMAGING; DIFFUSION TENSOR IMAGING; DRUG EFFECTS; ORGAN SIZE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; UTAH;

ADULT; BRAIN; COHORT STUDIES; DEPRESSIVE DISORDER; DIFFUSION TENSOR IMAGING; FEMALE; GRAY MATTER; HUMANS; INFANT, NEWBORN; MALE; ORGAN SIZE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN UPTAKE INHIBITORS; UTAH; WHITE MATTER;

EID: 84971379266     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2016.05.004     Document Type: Article

References (46)

1. Borue X., Chen J., Condron B.G. Developmental effects of SSRIs: lessons learned from animal studies. International journal of developmental neuroscience: the official journal of the International Society for. Dev. Neurosci. 2007, 25:341-347.
2. Boukhris T., Sheehy O., Mottron L., Berard A. Antidepressant use during pregnancy and the risk of autism spectrum disorder in children. JAMA Pediatr. 2016, 170:117-124.
3. Casper R.C., Fleisher B.E., Lee-Ancajas J.C., Gilles A., Gaylor E., DeBattista A., Hoyme H.E. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J. Pediatr. 2003, 142:402-408.
4. Casper R.C., Gilles A.A., Fleisher B.E., Baran J., Enns G., Lazzeroni L.C. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology 2011, 217:211-219.
5. Cooper W.O., Willy M.E., Pont S.J., Ray W.A. Increasing use of antidepressants in pregnancy. Am. J. Obstet. Gynecol. 2007, 196(544):e541-e545.
6. Croen L.A., Grether J.K., Yoshida C.K., Odouli R., Hendrick V. Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch. General. Psychiatry 2011, 68:1104-1112.
7. Deoni S.C., Dean D.C., O'Muircheartaigh J., Dirks H., Jerskey B.A. Investigating white matter development in infancy and early childhood using myelin water faction and relaxation time mapping. Neuroimage 2012, 63:1038-1053.
8. Fan L.W., Bhatt A., Tien L.T., Zheng B., Simpson K.L., Lin R.C., Cai Z., Kumar P., Pang Y. Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro. J. Neurochem. 2015, 133:532-543.
9. Feldman H.M., Yeatman J.D., Lee E.S., Barde L.H., Gaman-Bean S. Diffusion tensor imaging: a review for pediatric researchers and clinicians. J. Dev. Behav. Pediatr.: JDBP 2010, 31:346-356.
10. Gilmore J.H., Lin W., Prastawa M.W., Looney C.B., Vetsa Y.S., Knickmeyer R.C., Evans D.D., Smith J.K., Hamer R.M., Lieberman J.A., Gerig G. Regional gray matter growth, sexual dimorphism, and cerebral asymmetry in the neonatal brain. J. Neurosci. 2007, 27:1255-1260.
11. Gilmore J.H., Schmitt J.E., Knickmeyer R.C., Smith J.K., Lin W., Styner M., Gerig G., Neale M.C. Genetic and environmental contributions to neonatal brain structure: a twin study. Human. Brain Mapp. 2010, 31:1174-1182.
12. Gilmore J.H., Shi F., Woolson S.L., Knickmeyer R.C., Short S.J., Lin W., Zhu H., Hamer R.M., Styner M., Shen D. Longitudinal development of cortical and subcortical gray matter from birth to 2 years. Cereb. Cortex 2012, 22:2478-2485.
13. Glover M.E., Pugh P.C., Jackson N.L., Cohen J.L., Fant A.D., Akil H., Clinton S.M. Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats. Neuroscience 2015, 284:775-797.
14. Hanley G.E., Brain U., Oberlander T.F. Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect. Early Human. Dev. 2013, 89:519-524.
15. Hanley G.E., Oberlander T.F. The effect of perinatal exposures on the infant: antidepressants and depression. Best Practice Res. Clin. Obstet. Gynaecol. 2014, 28:37-48.
16. Harrington R.A., Lee L.C., Crum R.M., Zimmerman A.W., Hertz-Picciotto I. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 2014, 133:e1241-e1248.
17. Howell B.R., McCormack K.M., Grand A.P., Sawyer N.T., Zhang X., Maestripieri D., Hu X., Sanchez M.M. Brain white matter microstructure alterations in adolescent rhesus monkeys exposed to early life stress: associations with high cortisol during infancy. Biol. Mood Anxiety Disord. 2013, 3:21.
18. Huang H., Fan X., Williamson D.E., Rao U. White matter changes in healthy adolescents at familial risk for unipolar depression: a diffusion tensor imaging study. Neuropsychopharmacol.: . Publ. Am. Coll. Neuropsychopharmacol. 2011, 36:684-691.
19. Hviid A., Melbye M., Pasternak B. Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. New Engl. J. Med. 2013, 369:2406-2415.
20. Joshi S., Davis B., Jomier M., Gerig G. Unbiased diffeomorphic atlas construction for computational anatomy. NeuroImage 2004, 23(Suppl 1):S151-S160.
21. R.C., Knickmeyer, S., Meltzer-Brody, S., Woolson, R.M., Hamer, J.K., Smith, K., Lury, J.H., Gilmore, 2014. Rate of Chiari I Malformation in Children of Mothers with Depression with and without Prenatal SSRI Exposure. Neuropsychopharmacology.
22. Kroeze Y., Peeters D., Boulle F., van den Hove D.L., van Bokhoven H., Zhou H., Homberg J.R. Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus. Transl. Psychiatry 2015, 5:e642.
23. Kunz N., Zhang H., Vasung L., O'Brien K.R., Assaf Y., Lazeyras F., Alexander D.C., Huppi P.S. Assessing white matter microstructure of the newborn with multi-shell diffusion MRI and biophysical compartment models. NeuroImage 2014, 96:288-299.
24. Laine K., Heikkinen T., Ekblad U., Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch. General. Psychiatry 2003, 60:720-726.
25. Lee L.J. Neonatal fluoxetine exposure affects the neuronal structure in the somatosensory cortex and somatosensory-related behaviors in adolescent rats. Neurotox. Res. 2009, 15:212-223.
26. Li Y., Gilmore J.H., Shen D., Styner M., Lin W., Zhu H. Multiscale adaptive generalized estimating equations for longitudinal neuroimaging data. NeuroImage 2013, 72:91-105.
27. Liao C.C., Lee L.J. Neonatal fluoxetine exposure affects the action potential properties and dendritic development in cortical subplate neurons of rats. Toxicol. Lett. 2011, 207:314-321.
28. Monk C., Georgieff M.K., Osterholm E.A. Research review: maternal prenatal distress and poor nutrition - mutually influencing risk factors affecting infant neurocognitive development. J. Child. Psychol. Psychiatry 2013, 54:115-130.
29. Narboux-Neme N., Pavone L.M., Avallone L., Zhuang X., Gaspar P. Serotonin transporter transgenic (SERTcr)e (mouse line reveals developmental targets of serotonin specific reuptake inhibitors (SSRI)s). Neuropharmacology 2008, 55:994-1005.
30. Nulman I., Koren G., Rovet J., Barrera M., Pulver A., Streiner D., Feldman B. Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am. J. Psychiatry 2012, 169:1165-1174.
31. Pedersen L.H., Henriksen T.B., Olsen J. Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 2010, 125:e600-e608.
32. Rampono J., Simmer K., Ilett K.F., Hackett L.P., Doherty D.A., Elliot R., Kok C.H., Coenen A., Forman T. Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 2009, 42:95-100.
33. Salisbury A.L., Wisner K.L., Pearlstein T., Battle C.L., Stroud L., Lester B.M. Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress. Anxiety 2011, 28:1008-1019.
34. Sandman C.A., Buss C., Head K., Davis E.P. Fetal exposure to maternal depressive symptoms is associated with cortical thickness in late childhood. Biol. Psychiatry 2015, 77:324-334.
35. Silver M., Montana G., Nichols T.E., Alzheimer's Disease Neuroimaging I. False positives in neuroimaging genetics using voxel-based morphometry data. NeuroImage 2011, 54:992-1000.
36. Simpson K.L., Weaver K.J., de Villers-Sidani E., Lu J.Y., Cai Z., Pang Y., Rodriguez-Porcel F., Paul I.A., Merzenich M., Lin R.C. Perinatal antidepressant exposure alters cortical network function in rodents. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18465-18470.
37. Smith M.V., Sung A., Shah B., Mayes L., Klein D.S., Yonkers K.A. Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Human. Dev. 2013, 89:81-86.
38. Velasquez J.C., Goeden N., Bonnin A. Placental serotonin: implications for the developmental effects of SSRIs and maternal depression. Front. Cell. Neurosci. 2013, 7:47.
39. Verde A.R., Budin F., Berger J.B., Gupta A., Farzinfar M., Kaiser A., Ahn M., Johnson H., Matsui J., Hazlett H.C., Sharma A., Goodlett C., Shi Y., Gouttard S., Vachet C., Piven J., Zhu H., Gerig G., Styner M. UNC-Utah NA-MIC framework for DTI fiber tract analysis. Front Neuroinform 2014, 7:51.
40. Waters C.S., Hay D.F., Simmonds J.R., van Goozen S.H. Antenatal depression and children's developmental outcomes: potential mechanisms and treatment options. Eur. Child. Adolesc. Psychiatry 2014, 23:957-971.
41. Whitaker-Azmitia P.M. Behavioral and cellular consequences of increasing serotonergic activity during brain development: a role in autism?. Int. J. Dev. Neurosci. 2005, 23:75-83.
42. Worsley K., Marrett S., Neelin P., Vandal A.C., Friston K., Evans A.C. A unified statistical approach for determining significant voxels in images of cerebral activation. Hum. Brain Mapp. 1996, 4:58-73.
43. Xu Y., Sari Y., Zhou F.C. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res. Dev. Brain Res. 2004, 150:151-161.
44. Yonkers K.A., Wisner K.L., Stewart D.E., Oberlander T.F., Dell D.L., Stotland N., Ramin S., Chaudron L., Lockwood C. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Gen. Hosp. Psychiatry 2009, 31:403-413.
45. Yoshida S., Oishi K., Faria A.V., Mori S. Diffusion tensor imaging of normal brain development. Pediatr. Radiol. 2013, 43:15-27.
46. Zhu H., Kong L., Li R., Styner M., Gerig G., Lin W., Gilmore J.H. FADTTS: functional analysis of diffusion tensor tract statistics. Neuroimage 2011, 56:1412-1425.